Updates

Explore Medicines360’s latest news and resources

Press Releases

New Survey Reveals Increasing Barriers for Women Seeking Birth Control and Disproportionate Impact on Women of Color

Faced with job losses and disruption from the pandemic, women find it more challenging in 2020 to access birth control, a critical aspect of women’s health San Francisco – November 18, 2020 – Medicines360, a global nonprofit women’s health pharmaceutical organization fighting to make access to medicines for all women a reality, today released the […]

Read More >
Blog

Healthcare Policies Must Work for Women, Not Against Them

Challenges to accessing healthcare are not new for women; however, in the past year, several new roadblocks have hindered women’s access. These roadblocks span the gamut from the COVID-19 pandemic to policy changes that have impacted the fabric of women’s healthcare access. Also looming are significant changes to federal and state policies that threaten to […]

Read More >
Blog

Statement on Reproductive Justice

Medicines360 recognizes the importance of reproductive justice. We are aligned with the framework defined by SisterSong Women of Color Reproductive Justice Collective as “the human right to maintainpersonal bodily autonomy, have children, not have children, and parent the children we have in safe and sustainable communities.” The National Women’s Health Network (NWHN) and SisterSong issued […]

Read More >
Press Releases

Medicines360 Appoints Rolf Jansen as Vice President of Drug Development and Manufacturing

Jansen to Lead Product Expansion Focused on Essential Medicines Facing Access Challenges  SAN FRANCISCO – July 17, 2020 – Medicines360, a global nonprofit women’s health pharmaceutical organization, has appointed Rolf Jansen as the Vice President of Drug Development and Manufacturing. Mr. Jansen is a chemical engineer with more than thirty years of pharmaceutical experience developing […]

Read More >
Blog

Statement on SCOTUS Ruling

On July 8, the Supreme Court of the United States (SCOTUS) ruled to uphold the Trump Administration’s regulations allowing employers and insurers to decline providing contraception coverage because of religious or moral objections. Implementation of these rules will immediately and significantly decrease contraceptive access for 70,500 to 126,400 women. When the rules were implemented in […]

Read More >

FEATURED UPDATES

News

International Women’s Day at Direct Relief International

SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […]

Read More >
Press Releases

Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg

Strategic alliance will increase engagement with U.S. public health clinics and their patients about hormonal IUDs (long-acting reversible contraceptives, or LARCs) SAN FRANCISCO and CHARLESTON, S.C. – Medicines360 and Afaxys Pharma, LLC, two mission-driven, socially conscious women’s health pharmaceutical companies, today announced their collaboration to promote Medicines360’s intrauterine system (IUS), LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg, which is […]

Read More >
News

Medicines360 Expands Access To Contraception In Africa

FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar.

Read More >